References of "Evrard, Brigitte"
     in
Bookmark and Share    
Full Text
Peer Reviewed
See detailBetamethasone-in-cyclodextrin-in-liposome: The effect of cyclodextrins on encapsulation efficiency and release kinetics
Piel, Géraldine ULg; Piette, Marie ULg; Barillaro, Valery et al

in International Journal of Pharmaceutics (2006), 312(1-2), 75-82

Lipophilic drugs have limited solubility in phospholipid systems, hence maximum entrapment levels in liposomes are known to be low. "Drugs-in-cyclodextrin-in-liposome" systems were previously proposed to ... [more ▼]

Lipophilic drugs have limited solubility in phospholipid systems, hence maximum entrapment levels in liposomes are known to be low. "Drugs-in-cyclodextrin-in-liposome" systems were previously proposed to overcome this drawback but studies were limited to beta CD and HP beta CD. In some cases, other cyclodextrins may be more interesting than beta CD or HPPCD, such as methylated cyclodextrins. However, these cyclodextrins are known to extract lipid components from the lipid membrane, which may destabilize liposomes. We tested the influence of several cyclodextrins (beta CD, gamma CD, Dimeb, Trimeb, Crysmeb, Rameb, HP beta CD and HP gamma CD) on the aqueous solubility of betamethasone by phase solubility diagrams and on the encapsulation efficiency in liposomes. The release kinetics of betamethasone was studied using Franz diffusion cells. We showed that release kinetics are directly correlated with encapsulation efficiency, which is closely related to betamethasone concentration in cyclodextrin complex solution. No liposome destruction was observed, even with the testing of methylated cyclodextrins at the highest concentration (40 mM). This can be explained by the fact that these cyclodextrins have a higher affinity for betamethasone than for cholesterol. This was proved by the comparison of phase solubility diagrams of both betamethasone and cholesterol. (c) 2006 Elsevier B.V. All rights reserved. [less ▲]

Detailed reference viewed: 96 (13 ULg)
Full Text
Peer Reviewed
See detailInhaled fluticasone reduces bronchial responsiveness and airway inflammation in cats with mild chronic bronchitis
Kirschvink, N; Leemans, Jérôme ULg; Delvaux, François et al

in Journal of Feline Medicine and Surgery (2006), 8(1), 45-54

This study investigated the effect of inhaled fluticasone on lower airway inflammation and bronchial responsiveness (BR) to inhaled carbachol in cats with very mild, chronic bronchitis (n = 5) that were ... [more ▼]

This study investigated the effect of inhaled fluticasone on lower airway inflammation and bronchial responsiveness (BR) to inhaled carbachol in cats with very mild, chronic bronchitis (n = 5) that were compared with healthy cats serving as controls (n = 6). Chest radiographs, BR tests performed non-invasively by barometric whole body plethysmography (BWBP) and bronchoalveolar lavage (BAL) were performed before and after treatment. BR was quantified by calculating the concentration of carbachol inducing bronchoconstriction (C-Penh300%), defined as a 300% increase of baseline Penh, an index of bronchoconstriction obtained by BWBP. BAL fluid was analyzed cytologically and the oxidant marker 8-iso-PGF2α was determined. At test 1, healthy cats and cats with bronchitis were untreated, whereas for test 2 inhalant fluticasone (250 μg once daily) was administrated for 2 consecutive weeks to cats with bronchitis. Control cats remained untreated. Inhaled fluticasone induced a significant increase in C-Penh300% and a significant decrease of BAL fluid total cells, macrophages, neutrophils and 8-iso-PGF2α in cats with bronchitis, whilst untreated control cats did not show significant changes over time. This study shows that a 2-week fluticasone treatment significantly reduced lower airway inflammation in very mild bronchitis. BR could be successfully monitored in cats using BWPB and decreased significantly in response to inhaled fluticasone. 8-Iso-PGF2α in BAL fluid was responsive to treatment and appeared as a sensitive biomarker of lower airway inflammation in cats. [less ▲]

Detailed reference viewed: 42 (5 ULg)
Full Text
Peer Reviewed
See detailEffect of ß-Cyclodextrin Derivatives on Bronchial Epithelial Cell Layer Permeability
Bosquillon, C; Belhadj Salem, L; Hernandez, E et al

in Delivery to the lung (2006), 17

Cyclodextrins have been identified as promising adjuvants for pulmonary drug delivery. However, concerns regarding possible adverse effects on the respiratory epithelium may limit their development in ... [more ▼]

Cyclodextrins have been identified as promising adjuvants for pulmonary drug delivery. However, concerns regarding possible adverse effects on the respiratory epithelium may limit their development in inhaled products. Concentrations (10-50 mM) of three ß-cyclodextrin derivatives, randomly methylated ß-cyclodextrin (RAMEB), hydroxypropyl-ß-cyclodextrin (HPßCD) and Kleptose® CRYSMEB, were applied to human respiratory epithelial (Calu-3) cell layers and effects on permeability were evaluated by 14C-mannitol permeability and transepithelial electrical resistance (TEER) measurements. Each cyclodextrin produced a concentration-dependent increase in mannitol flux which was associated with a drop in TEER. Increases in mannitol flux were the highest after exposure to RAMEB and were not apparent until a 50-60% reduction in TEER was reached. Disrupted cell layers recovered to their initial TEER value in less than 24 h except after exposure to high concentrations of RAMEB. Perturbations of the Calu-3 cell layers were shown to be dependent on cyclodextrin concentration, as well as chemical derivatisation, and were reversible in all but the most severe cases. [less ▲]

Detailed reference viewed: 46 (10 ULg)
Full Text
Peer Reviewed
See detailUse of the MTT assay to evaluate the biocompatibility of beta-cyclodextrin derivatives with respiratory epithelial cells
Patel, J.; Belhadj Salem; Martin, G. P. et al

in Journal of Pharmacy and Pharmacology (2006), 58(58), 64-65

Detailed reference viewed: 79 (1 ULg)
Peer Reviewed
See detailMulti-biomaterial for controlled release of active substances
Zalfen, Alina; Nizet, Dominique; Jérôme, Christine ULg et al

Poster (2006)

Detailed reference viewed: 17 (0 ULg)
Peer Reviewed
See detailEffect of cyclodextrins on the membrane permeability of liposomes
Piel, Géraldine ULg; Piette, Marie ULg; Barillaro, Valery et al

Poster (2005, November)

Detailed reference viewed: 44 (3 ULg)
Full Text
Peer Reviewed
See detailAutomated method for the determination of a new matrix metalloproteinase inhibitor in ovine plasma and serum by coupling of restricted access material for on-line sample clean-up to liquid chromatography
Chiap, Patrice ULg; Piette, Marie ULg; Evrard, Brigitte ULg et al

in Journal of Chromatography. B : Analytical Technologies in the Biomedical & Life Sciences (2005), 817(1), 109-117

A fully automated liquid chromatographic method was developed for the determination of Ro 28-2653, a new synthetic inhibitor of matrix metalloproteinases (MMPs), in ovine serum and plasma. The method was ... [more ▼]

A fully automated liquid chromatographic method was developed for the determination of Ro 28-2653, a new synthetic inhibitor of matrix metalloproteinases (MMPs), in ovine serum and plasma. The method was based on the coupling of a pre-column packed with restricted access material, namely LiChrospher RP-8 ADS (alkyl diol silica), for sample clean-up to an analytical column containing octyl silica stationary phase. One hundred mul of biological sample, to which 2-propanol was automatically added, were injected onto the ADS pre-column, which was then washed with a washing liquid consisting of a mixture of 25 mM phosphate buffer (pH 7.0) and acetonitrile (90: 10; v/v) for 10 min. By rotation of the switching valve, the analyte was then eluted in the back-flush mode with the LC mobile phase composed of a mixture of acetonitrile and 25 mM phosphate buffer (pH 7.0) (57:43; v/v). The UV detection was performed at 395 nm. The main parameters likely to influence the sample preparation technique were investigated. The method was then validated over a concentration range from 17.5 to 1950 ng/mI, the first concentration level corresponding to the lower limit of quantitation. At this concentration level, the mean bias and the R.S.D. value for intermediate precision were -2.4% and 4.2%, respectively. (C) 2004 Elsevier B.V. All rights reserved. [less ▲]

Detailed reference viewed: 72 (19 ULg)
Full Text
Peer Reviewed
See detailSolid Lipid Microparticles: Formulation, Preparation, Characterisation, Drug Release and Applications
Jaspart, Séverine ULg; Piel, Géraldine ULg; Delattre, Luc ULg et al

in Expert Opinion on Drug Delivery (2005), 2(1), 75-87

This review details the properties of solid lipid microparticles (SLMs): a promising drug carrier system that has been until now rather unexploited. First, the advantages of SLMs compared with other drug ... [more ▼]

This review details the properties of solid lipid microparticles (SLMs): a promising drug carrier system that has been until now rather unexploited. First, the advantages of SLMs compared with other drug carrier systems are listed. Then an overview of SLM manufacturing compounds and techniques is presented. A detailed discussion of the characteristics of SLMs follows, and includes the determination of particle size distribution, the determination of SLM morphology, the solid-state analysis, the determination of SLM drug loading and the factors influencing it. The in vitro drug release studies that have been carried out so far and the parameters affecting them are also described. Some preliminary in vivo aspects (in vivo drug release studies, biocompatibility studies and in vivo fate) are also considered. [less ▲]

Detailed reference viewed: 65 (4 ULg)
Peer Reviewed
See detailIn vitro release of salbutamol acetonide from solid lipid nanoparticles
Jaspart, Séverine ULg; Bodson, Cédric; Bertholet, Pascal et al

in Proceedings of 1st Pharmaceutical Sciences Fair and Exhibition (2005)

Detailed reference viewed: 34 (1 ULg)
Peer Reviewed
See detailEvaluation of the pulmonary inflammation and bronchial hyperresponsiveness in healthy mice induced by inhaled cyclodextrins
Guéders, Maud ULg; Bertholet, P.; Barillaro, Valery et al

in Journal of inclusion Phenomena and Macrocyclic Chesmistry (2005)

Detailed reference viewed: 16 (1 ULg)